143 related articles for article (PubMed ID: 36272267)
1. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
Mirzaei S; Paskeh MDA; Entezari M; Mirmazloomi SR; Hassanpoor A; Aboutalebi M; Rezaei S; Hejazi ES; Kakavand A; Heidari H; Salimimoghadam S; Taheriazam A; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Dec; 156():113860. PubMed ID: 36272267
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs regulating SOX2 in cancer progression and therapy response.
Mirzaei S; Saebfar H; Gholami MH; Hashemi F; Zarrabi A; Zabolian A; Entezari M; Hushmandi K; Samarghandian S; Aref AR; Ashrafizadeh M; Khan H
Expert Rev Mol Med; 2021 Sep; 23():e13. PubMed ID: 34583803
[TBL] [Abstract][Full Text] [Related]
3. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
4. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
5. SOX2 in development and cancer biology.
Novak D; Hüser L; Elton JJ; Umansky V; Altevogt P; Utikal J
Semin Cancer Biol; 2020 Dec; 67(Pt 1):74-82. PubMed ID: 31412296
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability.
Xiao Y; Pan J; Geng Q; Wang G
FEBS Open Bio; 2019 Jul; 9(7):1212-1222. PubMed ID: 31037832
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion.
Wang Y; Zhou J; Wang Z; Wang P; Li S
Biochem Biophys Res Commun; 2017 Nov; 493(1):429-436. PubMed ID: 28882595
[TBL] [Abstract][Full Text] [Related]
8. SOX2-associated signaling pathways regulate biological phenotypes of cancers.
Ding LN; Yu YY; Ma CJ; Lei CJ; Zhang HB
Biomed Pharmacother; 2023 Apr; 160():114336. PubMed ID: 36738502
[TBL] [Abstract][Full Text] [Related]
9. The dark side of SOX2: cancer - a comprehensive overview.
Wuebben EL; Rizzino A
Oncotarget; 2017 Jul; 8(27):44917-44943. PubMed ID: 28388544
[TBL] [Abstract][Full Text] [Related]
10. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
13. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
Forghanifard MM; Kasebi P; Abbaszadegan MR
Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
[TBL] [Abstract][Full Text] [Related]
14. The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy.
Huang P; Wen F; Li Y; Li Q
Life Sci; 2024 May; 344():122576. PubMed ID: 38492918
[TBL] [Abstract][Full Text] [Related]
15. Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells.
Bigdelou Z; Mortazavi Y; Saltanatpour Z; Asadi Z; Kadivar M; Johari B
Mol Biol Rep; 2020 Mar; 47(3):1859-1869. PubMed ID: 32016633
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA
Chen X; Xie R; Gu P; Huang M; Han J; Dong W; Xie W; Wang B; He W; Zhong G; Chen Z; Huang J; Lin T
Clin Cancer Res; 2019 Feb; 25(4):1389-1403. PubMed ID: 30397178
[TBL] [Abstract][Full Text] [Related]
17. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM
Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
19. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
20. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.
Forghanifard MM; Ardalan Khales S; Javdani-Mallak A; Rad A; Farshchian M; Abbaszadegan MR
Med Oncol; 2014 Apr; 31(4):922. PubMed ID: 24659265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
